111823.
(a) A device that collects or analyzes information originating from a physiological source, including, but not limited to, heartbeat, blood pressure, body temperature, or blood oxygen, and is not subject to regulation under the federal act (21 U.S.C. Sec. 301 et seq.), or any other federal law or regulation, including the Medical Device Amendments of 1976 (21 U.S.C. Sec. 360c et seq.), shall have a legible disclosure affixed on the product, packaging, or within informational materials included within the packaging for the device, or within user instructions, or a combination thereof, that includes limitations known by the manufacturer on the effectiveness of the device for the device’s intended population because of certain characteristics of the person using the device or of the person on which the device is being used, including, but not limited to, age, color, disability, ethnicity, gender, or race.(b) This chapter shall become operative on January 1, 2027.